NCODA publishes a Positive Quality Intervention recommending screening for DPD/DPYD prior to the use of fluoropyrimidine based chemotherapy

The National Community Oncology Dispensing Association (NCODA) mission is to ” empower the medically-integrated oncology team to deliver positive, patient-centered outcomes (emphasis added) by providing leadership, expertise, quality standards and best practices.”

NCODA has published a Positive Quality Intervention recommending screening for DPD/DPYD prior to the use of fluoropyrimidine based chemotherapy: see https://www.ncoda.org/dpyd-testing-prior-to-fluoropyrimidine-treatment/